ANTICANCER NUCLEAR HORMONE RECEPTOR TARGETING COMPOUNDS

MA52642AUndetermined Publication Date: 2021-03-24NUVATION BIO INC

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA52642
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2018-05-14
Filing Date: 2019-05-14
Publication Date: 2021-03-24

Application Information

Patent Timeline

14 May 2018

Priority

14 May 2019

Application

MA52642

24 Mar 2021

Publication

MA52642A

IPC: A61K45/06; C07D401/14

CPC: A61P35/00; C07D401/14; C07D403/10; C07D403/14; C07D413/14; C07D417/14; C07D451/02; C07D471/04

Inventors: BARDE Anup; CHAKRAVARTY Sarvajit

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.